查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1544092

术中神经监测的全球市场

Intraoperative Neuromonitoring
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球术中神经监测市场将达到 55 亿美元

术中神经监测的全球市场预计 2023 年为 39 亿美元，预计到 2030 年将达到 55 亿美元，2023 年至 2030 年复合年增长率为 4.8%。内部资源神经监测是本报告分析的细分市场之一，预计复合年增长率为 3.9%，到分析期结束时将达到 29 亿美元。在分析期间，外包术中神经监测领域的复合年增长率预计为 6.0%。

美国市场预估成长11亿美元，中国复合年增长率4.6%

预计 2023 年美国术中神经监测市场规模将达 11 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达到8.694亿美元，2023-2030年分析期间复合年增长率为4.6%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 4.4% 和 4.2%。在欧洲，德国的复合年增长率预计为 4.9%。

全球术中神经监测市场—主要趋势与驱动因素总结

什么是术中神经监测？

术中神经监测 (IONM) 是一种在手术期间用于监测神经结构（例如神经、脊髓和大脑部分）功能完整性的技术。透过提供这些结构电活动的即时回馈，IONM 可以帮助外科医生避免对关键神经途径的损伤，并降低术后神经病变的风险。这项技术对于确保手术安全至关重要，尤其是涉及脊椎、大脑和周边神经的手术，即使是最轻微的错误也可能导致严重的併发症。 IONM 的使用变得越来越广泛，因为它可以改善手术结果、最大限度地降低风险并有助于提高复杂和精细手术的整体安全性。

技术进步如何形塑术中神经监测市场？

技术进步正在显着塑造术中神经监测市场，特别是透过监测技术、讯号处理以及与手术系统整合方面的创新。先进电生理监测技术的发展，如体感诱发电位（SSEP）、运动诱发电位（MEP）和肌电图（EMG），扩大了手术期间可监测的神经结构的范围，使外科医生能够提供神经功能的综合反馈。讯号处理演算法的改进提高了神经监测资料的准确性和可靠性，从而可以更准确地检测手术期间的潜在问题。此外，IONM 与先进影像处理技术和机器人手术系统的整合进一步提高了神经监测的有效性，并在复杂手术过程中提供更好的可视化和控制。这些技术趋势显着提高了手术安全性和治疗效果，从而增加了 IONM 在各个手术领域的采用。

为什么外科手术中对术中神经监测的需求不断增加？

由于手术复杂性增加、脊椎和神经外科手术发生率上升以及对病人安全的日益重视，手术环境中对术中神经监测的需求不断增加。随着外科手术变得更加复杂并涉及更高的风险，即时监测神经结构对于防止意外损伤和确保积极的结果变得至关重要。脊髓疾病、脑肿瘤和周边神经损伤等通常需要复杂手术介入的疾病的盛行率不断上升，也推动了对 IONM 的需求，因为它有助于降低术后神经併发症的风险。此外，外科医生和患者越来越意识到神经监测的好处，越来越多的医疗保健专业人员采用 IONM 作为提高手术安全性的标准技术，也推动了市场的扩张。随着医疗保健行业继续优先考虑患者的治疗效果并努力最大程度地降低手术风险，预计对术中神经监测的需求将会成长。

推动术中神经监测市场成长的因素有哪些？

术中神经监测市场的成长是由与技术进步、外科手术复杂性增加以及对提高病患安全的重视相关的几个因素所推动的。主要驱动力之一是神经监测技术的进步，该技术大大扩展了 IONM 在各种外科专业中的功能和应用。脊椎、神经外科和整形外科手术尤其容易出现神经系统併发症，数量不断增加，也推动了对 IONM 作为确保手术成功的关键工具的需求。越来越多地采用微创手术技术，以及 IONM 与机器人和导航工具等先进手术系统的持续集成，也透过提高手术精度和安全性进一步推动市场成长。此外，对降低医疗成本和改善患者治疗效果的日益关注正在推动 IONM 作为预防措施的采用，以避免代价高昂的术后併发症。由于这些因素继续影响手术前景，在手术过程中需要更先进、更可靠的全面覆盖的推动下，市场前景将持续增长，因此需要一个全面的监测解决方案。

受访企业范例（共46家）

  • Cadwell Industries, Inc.
  • Computational Diagnostics, Inc.
  • Medtronic PLC
  • Natus Medical, Inc.
  • NuVasive, Inc.
  • SpecialtyCare

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP12826

Global Intraoperative Neuromonitoring Market to Reach US$5.5 Billion by 2030

The global market for Intraoperative Neuromonitoring estimated at US$3.9 Billion in the year 2023, is expected to reach US$5.5 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Insourced Intraoperative Neuromonitoring, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$2.9 Billion by the end of the analysis period. Growth in the Outsourced Intraoperative Neuromonitoring segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 4.6% CAGR

The Intraoperative Neuromonitoring market in the U.S. is estimated at US$1.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$869.4 Million by the year 2030 trailing a CAGR of 4.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Intraoperative Neuromonitoring Market - Key Trends & Drivers Summarized

What Is Intraoperative Neuromonitoring and Why Is It Crucial for Surgical Safety?

Intraoperative neuromonitoring (IONM) is a technique used during surgeries to monitor the functional integrity of neural structures such as nerves, spinal cord, and parts of the brain. By providing real-time feedback on the electrical activity of these structures, IONM helps surgeons avoid injury to critical neural pathways, thereby reducing the risk of postoperative neurological deficits. This technique is crucial for surgical safety, especially in procedures involving the spine, brain, and peripheral nerves, where even a minor error can lead to significant complications. The use of IONM has become increasingly widespread as it enhances surgical outcomes, minimizes risks, and contributes to the overall safety of complex and delicate procedures.

How Are Technological Advancements Shaping the Intraoperative Neuromonitoring Market?

Technological advancements are significantly shaping the intraoperative neuromonitoring market, particularly through innovations in monitoring techniques, signal processing, and integration with surgical systems. The development of advanced electrophysiological monitoring techniques, such as somatosensory evoked potentials (SSEPs), motor evoked potentials (MEPs), and electromyography (EMG), is expanding the range of neural structures that can be monitored during surgery, providing surgeons with comprehensive feedback on neural function. Improvements in signal processing algorithms are enhancing the accuracy and reliability of neuromonitoring data, enabling more precise detection of potential issues during surgery. Additionally, the integration of IONM with advanced imaging technologies and robotic surgical systems is further enhancing the effectiveness of neuromonitoring, allowing for better visualization and control during complex procedures. These technological trends are driving the adoption of IONM across various surgical disciplines, as they offer significant improvements in surgical safety and outcomes.

Why Is There an Increasing Demand for Intraoperative Neuromonitoring in Surgical Practices?

The demand for intraoperative neuromonitoring is increasing in surgical practices due to the growing complexity of surgeries, the rising incidence of spinal and neurosurgical procedures, and the increasing emphasis on patient safety. As surgical procedures become more advanced and involve higher risks, the need for real-time monitoring of neural structures has become essential to prevent inadvertent damage and ensure positive outcomes. The rising prevalence of conditions such as spinal disorders, brain tumors, and peripheral nerve injuries, which often require complex surgical interventions, is also driving demand for IONM, as it helps reduce the risk of postoperative neurological complications. Additionally, the growing awareness of the benefits of neuromonitoring among surgeons and patients is contributing to the market’s expansion, as more healthcare providers adopt IONM as a standard practice to enhance surgical safety. As the healthcare industry continues to prioritize patient outcomes and minimize surgical risks, the demand for intraoperative neuromonitoring is expected to grow.

What Factors Are Driving the Growth in the Intraoperative Neuromonitoring Market?

The growth in the intraoperative neuromonitoring market is driven by several factors related to technological advancements, the increasing complexity of surgical procedures, and the emphasis on improving patient safety. One of the primary drivers is the advancement in neuromonitoring technologies, which has significantly expanded the capabilities and applications of IONM in various surgical specialties. The rising number of spinal, neurosurgical, and orthopedic procedures, which are particularly prone to neural complications, is also fueling demand for IONM as a critical tool for ensuring surgical success. The growing adoption of minimally invasive surgical techniques and the integration of IONM with advanced surgical systems, such as robotics and navigation tools, are further propelling market growth by enhancing the precision and safety of surgeries. Additionally, the increasing focus on reducing healthcare costs and improving patient outcomes is driving the adoption of IONM as a preventive measure to avoid costly postoperative complications. As these factors continue to influence the surgical landscape, the intraoperative neuromonitoring market is expected to experience sustained growth, driven by the need for more advanced, reliable, and comprehensive monitoring solutions during surgery.

Select Competitors (Total 46 Featured) -

  • Cadwell Industries, Inc.
  • Computational Diagnostics, Inc.
  • Medtronic PLC
  • Natus Medical, Inc.
  • NuVasive, Inc.
  • SpecialtyCare

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Intraoperative Neuromonitoring - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Emphasis on Patient Safety Spurs Adoption of Intraoperative Neuromonitoring (IONM)
    • Advancements in Neuromonitoring Technologies Propel Market Growth
    • Shift Towards Minimally Invasive Surgeries Expands Market Opportunities for IONM
    • Technological Innovations Enhance the Accuracy and Reliability of Neuromonitoring
    • Increasing Use of IONM in Complex Spinal and Neurosurgical Procedures
    • Role of Intraoperative Neuromonitoring in Reducing Postoperative Complications
    • Growing Importance of Multimodal Monitoring Techniques in Surgery
    • Advancements in Real-Time Data Analysis and Interpretation Boost Market Adoption
    • Impact of Regulatory Standards and Guidelines on the Adoption of IONM
    • Expansion of IONM in Cardiovascular and Orthopedic Surgeries
    • Role of IONM in Enhancing Outcomes in Pediatric and Geriatric Surgery
    • Growing Demand for Remote Monitoring and Tele-IONM Services
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intraoperative Neuromonitoring Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intraoperative Neuromonitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Intraoperative Neuromonitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Insourced by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Insourced by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Insourced by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Outsourced by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Outsourced by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Outsourced by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • JAPAN
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • CHINA
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: China 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • EUROPE
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Intraoperative Neuromonitoring by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Intraoperative Neuromonitoring by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • FRANCE
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: France 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • GERMANY
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 41: Rest of Europe Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Rest of Europe Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Rest of Europe 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 44: Asia-Pacific Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Asia-Pacific Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Asia-Pacific 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 47: Rest of World Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of World Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of World 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030

IV. COMPETITION